Podcasts about Mechanism

If I asked you at the dinner table what you do as an online fitness coach and you can't tell me with absolute clarity, this episode and your offer is what you should work on right now. When it comes to success with our IFCA clients, when they finally nail their offer and they feel confident about it, everything else starts falling into place.  I'm going to give you some examples of offers I re-wrote for clients recently, how to think about your offer using the Hormozi Value Equation, how you can use our AI software to upgrade your offer, and more!   Time Stamps:   (0:52) Making A Better Offer (2:20) Benefits vs Results (3:26) IFCA Client Examples (6:11) Alex Hormozi's Value Equation (8:26) Selling The Vacation Not The Flight (9:11) The Mechanism (10:57) DM Me "AI Offer" ----------

Some of the biggest advances in women's health start with a simple question: why hasn't this been fixed yet? In this episode of BackTable OBGYN, Dr. Tess Kim, a minimally invasive gynecologic surgeon at Massachusetts General Hospital and the founder of Fruits of Labor, a women's health medical device innovation company, joins host Dr. Amy Park. --- SYNPOSIS Dr. Kim's educational journey began with medical school at Emory, followed by residency at Beth Israel Deaconess Hospital, and fellowship training at MGH. She discusses the founding of Fruits of Labor, which began with the Perry Peach—a warm compress device designed to reduce severe perineal tearing during childbirth and now acquired by Medicines360. Dr. Kim also talks about her creative process, the importance of addressing historically neglected areas in women's health, and the potential impact of her new project, Mellomallows, which aims to reduce discomfort during gynecological procedures such as IUD placement. The conversation concludes with a discussion of the challenges and opportunities in women's health innovation, the significance of supportive networks, and the role of passion and commitment in driving meaningful change. --- TIMESTAMPS 00:00 - Introduction02:03 - The Birth of PeriPeach: Addressing Severe Tearing06:51 - New Medical Devices: Mellomallows08:41 - The Creation and Mechanism of PeriPeach 11:11 - Company Development: Mentorship and Resources17:37 - Pitching Practice and Experience 19:26 - Project Funding and Working with Medicines36021:51 - Advice for Aspiring Innovators23:52 - Concerns About AI in Healthcare26:48 - Innovations in Women's Health29:06 - Challenges in Academic Medicine32:01 - The Importance of Female Innovators34:00 - Forming a Startup in Women's Health36:10 - Parting Advice for Future Innovators37:37 - The Future of Women's Health Innovations40:10 - Conclusion --- RESOURCES Fruits of Labor website:https://www.fruitsoflabormed.com/home PeriPeach website:https://www.peripeach.com/

In the late 1990s, a strange carbon molecule quietly delivered the single longest lifespan extension ever recorded in mammals. The rats lived about 90% longer, and almost no one was paying attention. This episode breaks down what that molecule is, why it works, and how it may upgrade mitochondria, sleep, and human performance when used correctly. Watch this episode on YouTube for the full video experience: https://www.youtube.com/@DaveAspreyBPR Host Dave Asprey sits down with Chris Burres, founder and chief scientist of MyVitalC and the original long-term manufacturer of carbon 60. Chris has produced this Nobel Prize–winning molecule since the early 1990s, supplying research institutions around the world years before it ever entered the biohacking space. He explains how carbon 60 behaves differently from traditional antioxidants, why stability and concentration used to be major problems, and how modern manufacturing finally made real-world use possible. Chris is also a published author, longevity summit host, patent holder, and longtime science communicator who brings rare clarity and humor to complex biology. Dave and Chris explore how carbon 60 interacts with mitochondria, oxidative stress, metabolism, and electrical signaling in the body, and where it fits alongside ketosis, nootropics, supplements, and functional medicine strategies. They also unpack why improving mitochondrial function often shows up first as better energy and sleep optimization, and how that foundation supports longevity, brain optimization, and Smarter Not Harder performance. Along the way, Dave shares his own early experience with C60, how he uses it today, and why it now shows up even in his Danger Coffee stack. You'll Learn: • Why carbon 60 produced the longest longevity result ever recorded in mammal studies • How mitochondrial efficiency shapes energy, sleep, and human performance • What makes C60 a selective antioxidant instead of a blunt one • Why purity, concentration, and stability determine whether a supplement works • How carbon 60 fits into biohacking stacks built around ketosis and metabolism • What users report first, from focus and resilience to deeper sleep • Why mitochondrial health underpins long-term anti-aging strategies • How to think about supplements through a Smarter Not Harder lens Dave Asprey is a four time New York Times bestselling author, founder of Bulletproof Coffee, and the father of biohacking. With over 1,000 interviews and 1 million monthly listeners, The Human Upgrade is the top podcast for people who want to take control of their biology, extend their longevity, and optimize every system in the body and mind. Each episode features cutting edge insights in health, performance, neuroscience, supplements, nutrition, hacking, emotional intelligence, and conscious living. Affiliates: Vibrant Blue Oils | Grab a full-size bottle for over 50% off at https://vibrantblueoils.com/dave. ECHO Water | Go to http://echowater.com/dave and use code DAVE10 for 10% off your ECHO Flask. Dave Asprey is a four-time New York Times bestselling author, founder of Bulletproof Coffee, and the father of biohacking. With over 1,000 interviews and 1 million monthly listeners, The Human Upgrade brings you the knowledge to take control of your biology, extend your longevity, and optimize every system in your body and mind. Each episode delivers cutting-edge insights in health, performance, neuroscience, supplements, nutrition, biohacking, emotional intelligence, and conscious living. New episodes are released every Tuesday, Thursday, Friday, and Sunday (BONUS). Dave asks the questions no one else will and gives you real tools to become stronger, smarter, and more resilient. Keywords: carbon 60 podcast, C60 longevity science, biohacking mitochondria, mitochondrial optimization podcast, anti-aging supplements science, human performance longevity, selective antioxidant mitochondria, sleep optimization biohacking, brain optimization supplements, nootropics longevity stack, ketosis metabolism longevity, functional medicine mitochondria, oxidative stress longevity, carbon 60 supplement science, MyVitalC podcast, Chris Burres interview, Dave Asprey biohacking, Danger Coffee stack, Smarter Not Harder longevity, Nobel Prize molecule longevity, mitochondrial health podcast Resources: • Get a 30% discount on your next purchase of ESS60 at: https://www.myvitalc.com/pages/humanupgradeod?ref=humanupgrade • Get My 2026 Biohacking Trends Report: https://daveasprey.com/2026-biohacking-trends-report/ • Join My Low-Oxalate 30-Day Challenge: https://daveasprey.com/2026-low-ox-reset/ • Dave Asprey's Latest News | Go to https://daveasprey.com/ to join Inside Track today. • Danger Coffee: https://dangercoffee.com/discount/dave15 • My Daily Supplements: SuppGrade Labs (15% Off) • Favorite Blue Light Blocking Glasses: TrueDark (15% Off) • Dave Asprey's BEYOND Conference: https://beyondconference.com • Dave Asprey's New Book – Heavily Meditated: https://daveasprey.com/heavily-meditated • Upgrade Collective: https://www.ourupgradecollective.com • Upgrade Labs: https://upgradelabs.com Timestamps: 0:00 – Introduction & C60 Discovery 4:04 – The Molecule & Nobel Prize 8:27 – Quantum Properties & Superconductivity 11:16 – Rat Longevity Study Results 14:33 – Selective Antioxidant Properties 15:51 – User Experience & Timeline 18:15 – Biological Age Testing 21:33 – Why Oil & Product Development 23:32 – Mechanism of Action 28:13 – Biohacker Discovery Story 30:03 – FDA & Supplement Regulation 33:50 – Migraines & Clinical Observations 37:53 – Athletic Performance 40:43 – Stacking & Contraindications 45:57 – Skincare Product 50:43 – Who Benefits Most 1:00:37 – Mitochondria & Consciousness 1:02:03 – Where to Buy & Closing See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

An episode discussing the pending gap law, corruption, army spending, rebuilding trust in the banking sector, prospects for Lebanese-Israeli relations and America's diplomatic role at large. With economist and Arab News columnist Nadim Shehadi. Check out Nadim Shehadi's article 'Lebanon is not resilient, it is traumatized': https://www.arabnews.com/node/2144181 and Michael Young's piece 'A Mechanism of Coercion': https://carnegieendowment.org/middle-east/diwan/2026/01/a-mechanism-of-coercion The podcast is only made possible through listener and viewer donations. Please help support The Beirut Banyan by contributing via PayPal: https://www.paypal.me/walkbeirut Or donating through our Patreon page: https://www.patreon.com/thebeirutbanyan Subscribe to our YouTube channel and your preferred audio platform. Follow us on Facebook, Instagram & Twitter: @thebeirutbanyan And check out our website: www.beirutbanyan.com Timestamps: 0:00 Intro 4:36 Protecting the criminals 7:08 Diversion from the real issues 9:05 Gap Law 14:43 Minimizing the state 20:30 Defending unpopular figures 22:18 Corruption in Lebanon 24:24 Investigations 30:38 Constant battering 33:10 Army spending & budget 38:10 Key element is trust 42:23 Discussion on Israel 44:29 Michael Young 46:29 “A Mechanism of Coercion” 51:12 Normalization - an internal matter 1:00:25 American positioning 1:06:07 “We'll just go” 1:13:00 Turning 70

How to turn troubles into liftings

On this week’s episode, we’re continuing our Guidelines Series exploring the 2022 ESC/ERS Guidelines for the diagnosis and treatment of Pulmonary Hypertension. If you missed our first episode in the series, give it a listen to hear about the most recent recommendations regarding Pulmonary Hypertension definitions, screening, and diagnostics. Today, we’re talking about the next steps after diagnosis. Specifically, we’ll be discussing risk stratification, establishing treatment goals, and metrics for re-evaluation. We’ll additionally introduce the mainstays of pharmacologic therapy for Pulmonary Hypertension. Meet Our Co-Hosts Rupali Sood  grew up in Las Vegas, Nevada and made her way over to Baltimore for medical school at Johns Hopkins. She then completed her internal medicine residency training at Massachusetts General Hospital before returning back to Johns Hopkins, where she is currently a pulmonary and critical care medicine fellow. Rupali’s interests include interstitial lung disease, particularly as related to oncologic drugs, and bedside medical education. Tom Di Vitantonio  is originally from New Jersey and attended medical school at Rutgers, New Jersey Medical School in Newark. He then completed his internal medicine residency at Weill Cornell, where he also served as a chief resident. He currently is a pulmonary and critical care medicine fellow at Johns Hopkins, and he’s passionate about caring for critically ill patients, how we approach the management of pulmonary embolism, and also about medical education of trainees to help them be more confident and patient centered. Key Learning Points 1) Episode Roadmap How to set treatment goals, assess symptom burden, and risk-stratify patients with suspected/confirmed pulmonary arterial hypertension (PAH). What tools to use to re-evaluate patients on treatment Intro to major PAH medication classes and how they map to pathways. 2) Case-based diagnostic reasoning Patient: 37-year-old woman with exertional dyspnea, mild edema, abnormal echo, telangiectasias + epistaxis → raises suspicion for HHT (hereditary hemorrhagic telangiectasia) and/or early connective tissue disease. Key reasoning move: start broad (Groups 2–5) and narrow using history/exam/testing. In a young patient without obvious left heart or lung disease, think more about Group 1 PAH (idiopathic/heritable/associated). HHT teaching point: HHT can cause PH in more than one way: More common: high-output PH from AVMs (often hepatic/pulmonary) Rare (1–2% mentioned): true PAH phenotype (vascular remodeling; associated with ALK1 in some patients), behaving like Group 1 PAH. 3) Functional class assessment WHO Functional Class: Class I: no symptoms with ordinary activity, only with exertion Class II: symptoms with ordinary activity Class III: symptoms with less-than-ordinary activity (can't do usual chores/shopping without dyspnea) Class IV: symptoms at rest Practical bedside tip they give: Ask if the patient can walk at their own pace or keep up with a similar-age peer/partner. If not, think Class II (or worse). 4) Risk stratification at diagnosis: why, how, and which tools Big principle: treatment choices are driven by risk, and the goal is to move patients to low-risk quickly. ESC/ERS approach at diagnosis (as described): Use a 3-strata model predicting 1-year mortality: Low: 20% ESC/ERS risk assessment variables (10 domains discussed): Clinical progression, signs of right heart failure, syncope WHO FC Biomarkers (NT-proBNP) Exercise capacity (6MWD) Hemodynamics Imaging (echo; sometimes cardiac MRI) CPET (peak VO₂; VE/VCO₂ slope) They note: even if you don't have everything, the calculator can still be useful with ≥3 variables. REVEAL 2.0: Builds on similar core variables but adds further patient context (demographics, renal function, BP, DLCO, etc.) Case result: both tools put her in intermediate risk (ESC/ERS ~1.6; REVEAL 2.0 score 8), underscoring that mild symptoms can still equal meaningful mortality risk. 5) Treatment goals and follow-up philosophy What they explicitly prioritize: Help patients feel better, live longer, and stay out of the hospital Use risk tools to communicate prognosis and to track improvement Reassess frequently (they mention ~every 3 months early on) until low risk is achieved “Time-to-low-risk” is an important treatment goal Also emphasized: The diagnosis is psychologically heavy; patients need clear counseling, reassurance about the plan, and connection to support groups. 6) Medication classes for the treatment of PAH Nitric oxide–cGMP pathway PDE5 inhibitors: sildenafil, tadalafil Soluble guanylate cyclase stimulator: riociguat Important safety point: don't combine PDE5 inhibitors with riociguat (risk of significant hypotension/hemodynamic effects) Endothelin receptor antagonists (ERAs) “-sentan” drugs: bosentan (less used due to side effects/interactions), ambrisentan, macitentan Teratogenicity emphasized Hepatotoxicity that requires LFT monitoring Can cause fluid retention and peripheral edema Prostacyclin pathway Prostacyclin analogs/agonists: Epoprostenol (potent; short half-life; IV administration) Treprostinil (IV/SubQ/oral/inhaled options) Selexipag (oral prostacyclin receptor agonist) 7) Sotatercept (post-guidelines) They note sotatercept wasn't in 2022 ESC/ERS but is now “a game changer” in practice: Mechanism: ligand trap affecting TGF-β signaling / remodeling biology Positioned as potentially more disease-modifying than pure vasodilators Still evolving: where to place it earlier vs later in regimens is an active question in the field 8) How risk category maps to initial treatment intensity General approach they outline: High risk at diagnosis: parenteral prostacyclin (IV/SubQ) strongly favored, often aggressive early Intermediate risk: at least dual oral therapy (typically PDE5i + ERA); escalate if not achieving low risk Low risk: at least one oral agent; many still use dual oral depending on etiology/trajectory For the case: intermediate-risk → start dual oral therapy (they mention tadalafil + ambrisentan as a typical choice), reassess in ~3 months; add a third agent (e.g., selexipag/prostacyclin pathway) if not low risk.  References and Further Reading Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P, Ferreira DS, Ghofrani HA, Giannakoulas G, Kiely DG, Mayer E, Meszaros G, Nagavci B, Olsson KM, Pepke-Zaba J, Quint JK, Rådegran G, Simonneau G, Sitbon O, Tonia T, Toshner M, Vachiery JL, Vonk Noordegraaf A, Delcroix M, Rosenkranz S; ESC/ERS Scientific Document Group. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022 Oct 11;43(38):3618-3731. doi: 10.1093/eurheartj/ehac237. Erratum in: Eur Heart J. 2023 Apr 17;44(15):1312. doi: 10.1093/eurheartj/ehad005. PMID: 36017548. Condon DF, Nickel NP, Anderson R, Mirza S, de Jesus Perez VA. The 6th World Symposium on Pulmonary Hypertension: what’s old is new. F1000Res. 2019 Jun 19;8:F1000 Faculty Rev-888. doi: 10.12688/f1000research.18811.1. PMID: 31249672; PMCID: PMC6584967. Maron BA. Revised Definition of Pulmonary Hypertension and Approach to Management: A Clinical Primer. J Am Heart Assoc. 2023 Apr 18;12(8):e029024. doi: 10.1161/JAHA.122.029024. Epub 2023 Apr 7. PMID: 37026538; PMCID: PMC10227272. Hoeper MM, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, McLaughlin VV, Preston IR, Souza R, Waxman AB, Grünig E, Kopeć G, Meyer G, Olsson KM, Rosenkranz S, Xu Y, Miller B, Fowler M, Butler J, Koglin J, de Oliveira Pena J, Humbert M; STELLAR Trial Investigators. Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension. N Engl J Med. 2023 Apr 20;388(16):1478-1490. doi: 10.1056/NEJMoa2213558. Epub 2023 Mar 6. PMID: 36877098. Ruopp NF, Cockrill BA. Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review. JAMA. 2022 Apr 12;327(14):1379-1391. doi: 10.1001/jama.2022.4402. Erratum in: JAMA. 2022 Sep 6;328(9):892. doi: 10.1001/jama.2022.13696. PMID: 35412560.

"A saturated state is a state in which the conceptual or emotional object has absolute value, it is already stacked or closed to new meanings and therefore cannot undergo any kind of transformation. An unsaturated state, on the other hand, is a state in which the emotional or conceptual object is in an open state in which it is still open to transformation, to new meanings, to all kinds of change. What I think is interesting and important is to understand that one of the most difficult aims of working with traumatic objects is linked to this transformation from saturated to unsaturated states. Traumatic objects become fixed in a saturated state, which does not allow them to undergo any transformation within the psyche or within the therapeutic analytic process. The saturated state of traumatic events or objects is a frozen state in which therapy or analysis is used to preserve rather than intervene. This creates, in quite a few cases, a situation that I call false therapy or false analysis - a process, a therapeutic process in which very detailed materials are ostensibly presented, but in fact they are presented in a way that forces the therapist or  to either swallow them as they are, or vomit them up but not digest them because they are presented in a way that does not tolerate any intervention, any other point of view, any creation of movement within the given frozen narrative."   Episode Description: We begin with describing the difference between 'saturated' and 'unsaturated' memories - those that are frozen and without the freedom to reflect from those that contain the capacity to create new meaning. Dana emphasizes the importance of not simply collecting the particulars of a trauma, the 'notes', as much as attending to the nature of its delivery, the 'music' - "the way they tell the story." She presents a case involving 'parasitic language' where imitation of the other is at the level of fetishistic attachment lacking a voice of their own. In her countertransference she noted "I search for you - all I find is myself." We consider how this pseudo-relating induces a peculiar sense of closeness that ultimately contributes to a sense of claustrophobia in the analyst. She shares with us her personal story and reflects "Being a psychoanalyst doesn't mean giving up being a musician." Dana concludes with reading her final paragraph on 'forgiveness.'   Our Guest: Dana Amir, PhD., is a clinical psychologist, supervising and training analyst at the Israel Psychoanalytic Society, full professor, and head of the interdisciplinary doctoral program in psychoanalysis at the Zramim Postgraduate Psychoanalytic Psychotherapy Program at Haifa University, poetess and literature researcher. She is the author of seven poetry books, four memoirs in prose, and five psychoanalytic books published by Routledge. She was awarded literary as well as academic prizes, including seven international psychoanalytic awards, including the prestigious Sigourney Award (2025).   Recommended Readings: Amir, D. (2012). The Inner Witness. The International Journal of Psycho-analysis, 93:879–896. Amir, D. (2013). The Chameleon Language of Perversion. Psychoanalytic Dialogues, 23: 393-407.   Amir, D. (2016). The Metaphoric, the Metonymic and the Psychotic aspects of Obsessive-Sympomatology. International Journal of Psychoanalysis, 97, 259–280.  Amir, D. (2016). Hermetic Narratives and False Analysis: A Unique Variant of the Mechanism of Identification with the Aggressor. Psychoanalytic Review 103(4):539-54 Amir, D. (2023). "From Turning Away to Turning Toward: Adoption as Radical Hospitality". Psychoanalytic Perspectives, 21: 1–18. Amir, D. (2024). From mind-deadness to mindedness, from collaboration to cooperation. International Journal of Applied Psychoanalytic Studies, 21(4).

Your body already knows how to release stress — but you've been taught to suppress it. In this Mind Architect episode, Dr. David Berceli, creator of TRE (Tension and Trauma Releasing Exercises), reveals how our natural tremor mechanism can help us discharge tension, process trauma, and restore balance.Dr. David Berceli developed TRE while living in war zones, observing how humans naturally contract and release during threat. His method has now spread to over 80 countries. Joining him is Elvira Stanescu, an internationally certified TRE provider who has been practicing for nearly 5 years. Facilitating the conversation is our colleague Adrian Dinu. We explored the following topics in our conversation with David and Elvira: Why children shake naturally during stress — and why adults suppress itHow tremoring communicates between the nervous system and brainThe difference between exhausting yourself through exercise vs. actual releaseHow TRE can help parents, athletes, helping professionals, and couplesCurrent research on TRE and depression from studies in ChinaResources mentioned:Dr. David Berceli's book on TRE (now available in Romanian) David's website Romanian TRE Association TRE Global website Dr. David Berceli's YouTube Channel for research results and tutorialsFive ongoing research projects in China examining brain activity changes with TRE, including studies on depressed teenagers and their parentsYou can join us live during episode recordings and get your questions answered directly by becoming a Mind Architect Premium Member here Episode produced in partnership with Editura Herald."(00:00) Introduction: The body's hidden stress release mechanism""(01:50) Welcome and episode overview""(03:55) How Dr. Berceli discovered TRE in war zones""(06:30) The tremor mechanism in all mammals""(08:35) What happens in the body when we tremor""(12:01) How people experience tremoring in the beginning""(14:07) Tension vs. trauma: Why both matter""(17:09) The risk of overwhelm and how to self-regulate""(20:13) Dos and don'ts: How to start practicing TRE safely""(23:57) TRE vs. exhausting exercise: What's the difference?""(26:32) How the body takes over and releases patterns""(29:14) TRE for athletes and military personnel""(36:41) Cultural adaptations: China, Latin America, Romania""(44:50) TRE for helping professionals: Coaches, therapists, trainers""(50:13) How to integrate mind and body without forcing it""(54:30) TRE for parents and family systems""(01:00:00) The body's ability to heal specific injuries""(01:01:48) Collective trauma and healing in community""(01:11:50) The future: Vibration, sound, and medicine""(01:14:45) Resources and where to learn more"

Get The Algorithm Deletion Exercise here: https://fos.now/yt-gd-discover-elon-musk-algorithm-checklistDo you want my help systematizing your business? Go here: https://fos.now/yt-apply-569In this video, I reveal the 5 operating mechanisms Elon Musk deploys across every company he operates. More importantly, the versions of these mechanisms you can use without destroying your life, your team, or your sanity. If you've ever wondered how one human builds rockets, cars, AI labs, and brain interfaces all while melting down on Twitter, here's the real answer.Want to LEARN proven systems to grow your personal brand? Go here: https://fos.now/yt-newsletter-569Already doing $30K+/month? Come to my next free workshop and I'll show you how to systemize your business and get your time back → https://fos.now/yt-workshop-569Want to WORK with a team of A-players? Apply to Founder OS here: https://www.founderos.com/careersConnect with me: Website: https://fos.now/yt-founder-os-569Twitter: https://twitter.com/matt_gray_ LinkedIn: https://www.linkedin.com/in/mattgray1 TikTok: https://www.tiktok.com/@realmattgray Instagram: https://instagram.com/matthgray00:00 - Intro00:55 - Mechanism 1: Maniacal Sense of Urgency04:50 - Mechanism 2: The Algorithm10:45 - Mechanism 3: Build Unreasonable Teams13:42 - Mechanism 4: Iterate at The Speed of Thought16:34 - Mechanism 5: Engineer to Scale Beyond Yourself#onepersonbusiness #creatoreconomy #entrepreneurshipDisclaimer: Information shared here is for educational purposes only. Individuals and business owners should evaluate their own business strategies and identify any potential risks. The information shared here is not a guarantee of success. Your results may vary. This video shares my personal experience and growth building businesses over 15+ years of consistent effort. Your results will vary depending on your own actions, strategies, and circumstances.

Obstetrician-gynecologist Priya Panneerselvam discusses their article "How medicine reflects women's silence." Priya discusses how the quiet deference observed in their mother's generation continues to manifest in patients who apologize for their pain and hesitate to ask questions. The conversation explores the cultural and national forces that suppress female voices, linking personal family history to the broader political landscape regarding women's rights and leadership. By examining the cost of this inherited silence, Priya advocates for speaking out as an act of rebellion and gratitude for those who could not. Breaking this cycle is necessary to honor the past while securing a freer future. Partner with me on the KevinMD platform. With over three million monthly readers and half a million social media followers, I give you direct access to the doctors and patients who matter most. Whether you need a sponsored article, email campaign, video interview, or a spot right here on the podcast, I offer the trusted space your brand deserves to be heard. Let's work together to tell your story. PARTNER WITH KEVINMD → https://kevinmd.com/influencer SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

In this episode of Tech Talks, Mayer Brown partners Julian Dibbell, Brad Peterson, and Spencer Glende explore how companies can structure IP frameworks in contracts to support innovation in emerging technologies. They discuss why traditional contracting approaches often fall short in high-uncertainty environments and outline practical strategies—such as joint governance, flexibility, and aligned incentives—to help parties collaborate effectively and maximize long-term value. Show notes:  00:02 Introduction to IP Frameworks in Contracts for Emerging Technologies 2:00 Defining "emerging technology" 5:21 IP Contracting Perspective 11:09 How to build IP frameworks 12:19 Key 1: Clarity of Common Purpose 13:49 Key 2: Mechanism of Joint Steering Committees 19:26 Key 3: Maximizing Innovation Value 22:26 Key 4: Element of Flexibility and Optionality 26:24 Key Takeaways

"Send me a text"To learn more about the group coaching click here: https://creativethirst.com/group/You're spending $50 to acquire a customer who buys once and never returns. You've tested different creative, different audiences, different landing pages. Nothing works.The problem isn't your tactics. It's that you don't understand marketplace sophistication.Your market has heard every promise hundreds of times. They've tried dozens of supplements. They're skeptical and jaded. And you're marketing to them like it's 1995, making the same benefit promises everyone else makes.In this episode, you'll learn the five stages of marketplace sophistication and where supplement markets actually sit, why promises don't work anymore and what does (Unique Mechanisms), and how to create a Mechanism of Trust and Mechanism of Hope that makes your marketing actually work.Stop trying to out-promise your competition. Start competing on mechanism. That's supplement-specific thinking, and that's how you make marketing work in sophisticated markets.To learn more about the group coaching click here: https://creativethirst.com/group/If you're interested in working with me and my team to improve your supplement business. You can learn more at my website https://creativethirst.com Click here to grab your copy of the Health Supplement Ad Swipe Guide. Discover what really works in funnel marketing Need help increasing sales on your own? Click here Stuck at $1 - $5M in revenue? Click Here Case Study on how Creative Thirst added over $200,000 for one supplement brand

Adeline Atlas 11 X Published AUTHOR Digital Twin: Create Your AI Clone: https://www.soulreno.com/digital-twinSOS: School of Soul Vault: Full Access ALL SERIES⁠https://www.soulreno.com/joinus-202f0461-ba1e-4ff8-8111-9dee8c726340Instagram:⁠https://www.instagram.com/soulrenovation/Soul Renovation - BooksSoul Game - https://tinyurl.com/vay2xdcpWhy Play: ⁠https://tinyurl.com/2eh584jfHow To Play: ⁠https://tinyurl.com/2ad4msf3Digital Soul: https://tinyurl.com/3hk29s9xEvery Word: ⁠⁠http://tiny.cc/ihrs001Drain Me: ⁠https://tinyurl.com/bde5fnf4The Rabbit Hole: https://tinyurl.com/3swnmxfjDestiny Swapping: https://tinyurl.com/35dzpvssSpanish Editions:Every Word: https://tinyurl.com/ytec7cvcDrain Me: https://tinyurl.com/3jv4fc5n

In this episode of the Art of Catholic podcast, Matthew Leonard and author and professor Dr. Daniel Keating explore the astonishing Catholic doctrine of Deification.

Getting lots of feedback but making zero moves? That's what happens when your breakthrough session becomes an advice room. It can feel productive in the moment, but you leave with more opinions than decisions — and the same problem shows up again next week. This episode breaks down what real breakthrough sessions do differently and the nine mechanisms that lead to action.Topics discussed:Why breakthrough sessions often fail (01:16)Mechanism #1: name the real decision (02:39)Mechanism #2: separate facts from assumptions (03:11)Mechanism #3: find the hidden trade-offs (03:43)Mechanism #4: simplify the problem (04:17)Mechanism #5: advice comes after clarity (05:56)Mechanism #6: no competing for airtime (06:23)Mechanism #7: use healthy disagreement (06:45)Mechanism #8: ownership stays with the leader (07:11)Mechanism #9: proof comes after the session (07:30)Tired of feeling stuck? Download our FREE Limitless Growth eBook for strategies for continuous improvement, time management, and leadership skills that make an impact: https://meplusultra.com/growth/Download our FREE Client Centric Leader eBook for a deeper playbook on building loyalty no competitor can steal: https://meplusultra.com/ebooks/Apply for the Me Plus Ultra Mastermind to connect with elite entrepreneurs who solve real problems together: https://MePlusUltra.comSubscribe so you don't miss any episodes:Apple Podcasts: https://apple.co/3SN2fHnSpotify: https://open.spotify.com/show/74bfJL9J2fjevQEvi17ekUYouTube: https://www.youtube.com/@MePlusUltraNetwork/Connect with Me Plus Ultra:https://www.instagram.com/me_plus_ultra/https://www.facebook.com/MePlusUltra/https://www.facebook.com/groups/1011061052968028/https://x.com/Me_Plus_Ultra/Connect with Scott Joseph:https://www.linkedin.com/in/ScottJosephhttps://www.instagram.com/scotttjoseph/https://www.facebook.com/ScottTJoseph/https://x.com/ScottTJoseph1This episode was produced by Podcast Boutique https://www.podcastboutique.com

Pimavanserin is an atypical antipsychotic approved for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. Unlike traditional antipsychotics, it does not block dopamine receptors, making it a unique option for patients with Parkinson’s disease who are highly sensitive to dopamine antagonism. Mechanism of Action Pimavanserin works primarily as a selective serotonin 5-HT2A inverse agonist and antagonist, with minor activity at 5-HT2C receptors. This dopamine-sparing effect is the key reason it does not worsen motor symptoms in Parkinson’s disease. Adverse Effects The most commonly reported side effects include peripheral edema, nausea, confusion, and hallucinations. QT interval prolongation is a clinically important concern, especially in patients with existing cardiac risk factors. Somnolence may occur but is generally less prominent compared with dopamine-blocking antipsychotics. Warnings and Precautions Pimavanserin carries a boxed warning for increased mortality in elderly patients with dementia-related psychosis, consistent with other antipsychotics. It should not be used in patients with known QT prolongation, a history of ventricular arrhythmias, or in combination with other QT-prolonging agents when possible. Drug Interactions Strong CYP3A4 inhibitors, such as ketoconazole or clarithromycin, can significantly increase pimavanserin concentrations and require dose reduction. Strong CYP3A4 inducers, such as rifampin or carbamazepine, may reduce efficacy and should generally be avoided. Additive QT prolongation may occur when combined with other QT-prolonging medications, including certain antiarrhythmics, fluoroquinolones, and macrolide antibiotics. Be sure to check out our free Top 200 study guide – a 31 page PDF that is yours for FREE! Support The Podcast and Check Out These Amazing Resources! NAPLEX Study Materials BCPS Study Materials BCACP Study Materials BCGP Study Materials BCMTMS Study Materials Meded101 Guide to Nursing Pharmacology (Amazon Highly Rated) Guide to Drug Food Interactions (Amazon Best Seller) Pharmacy Technician Study Guide by Meded101

Certified coach and professor Kathleen Muldoon and co-founder of Ryan House and Children's Respite Homes of America Jonathan Cottor discuss the article "The need for pediatric respite care." Kathleen shares the personal story of raising her son Gideon who lives with over 42 medical diagnoses and explain why the family had to move across the country to find safety. They highlight the critical difference between taking a break and surviving the relentless cycle of 24/7 medical vigilance required for medically complex children. The conversation advocates for the expansion of pediatric respite homes in the U.S. while urging clinicians to recognize that caregiver well-being is inseparable from patient health. We must acknowledge that keeping a family together often depends on the support they receive outside the hospital walls. Partner with me on the KevinMD platform. With over three million monthly readers and half a million social media followers, I give you direct access to the doctors and patients who matter most. Whether you need a sponsored article, email campaign, video interview, or a spot right here on the podcast, I offer the trusted space your brand deserves to be heard. Let's work together to tell your story. PARTNER WITH KEVINMD → https://kevinmd.com/influencer SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

EU STRUGGLES WITH RUSSIAN ASSETS AND AID Colleague Judy Dempsey. Judy Dempsey discusses the EU's difficulty in utilizing frozen Russian assets and the "defeat" for Chancellor Merz regarding the funding mechanism for Ukraine. NUMBER 1 1890 SAXONY

What if thousands of steps of gentle walking aren't giving you the brain protection you think they are? In this solo episode, I break down one of the most important exercise studies published in Nature Communications and what it means for your brain, longevity, and Alzheimer's risk. Tracking over 73,000 people for eight years using wearables, the findings are shocking: one minute of vigorous exercise is worth up to 10 minutes of moderate activity — not the outdated 2-to-1 rule. For diabetes prevention, it's nearly 10-to-1. For cardiovascular mortality, it's 8-to-1. And here's what no one is saying: every outcome measured — heart disease, diabetes, metabolic dysfunction — is an independent risk factor for Alzheimer's and dementia. I explain why vigorous exercise is so powerful for your brain: shear stress that strengthens blood vessels, lactate that triggers BDNF, muscle fiber recruitment that protects against falls and cognitive decline, and glucose regulation that defends against insulin resistance — a driver of neurodegeneration. Think vigorous exercise is out of reach? Good news: the study defines it as brisk stairs, carrying groceries, or playing actively with your kids. No gym required — just effort. Just 3–4 minutes of vigorous bursts per day can reduce all-cause mortality by 40% and cardiovascular events by nearly 50%. For women over 40, this is critical. Two-thirds of Alzheimer's cases are women, and perimenopause is a vulnerability window for the brain. Vigorous exercise can partially compensate for declining estrogen by improving glucose regulation, reducing inflammation, and protecting the brain in ways gentle movement cannot. *** Reduce your risk of Alzheimer's with my science-backed protocol for women 30+: https://go.neuroathletics.com.au/brain-code-yt Subscribe to The Neuro Experience for more conversations at the intersection of brain science and performance. I'm committed to bringing you evidence-based insights that you can apply to your own health journey. *** A huge thank you to my sponsors for supporting this episode. Check them out and enjoy exclusive discounts: Rho NutritionYou can get 20% off with the code NEURO at https://rhonutrition.com Function HealthVisit https://functionhealth.com/louisa or use gift code NEURO100 at sign-up to own your health. AquaTruGo to https://AquaTru.com now for 20% off using promo code NEURO. TimelineHead to https://www.timeline.com/neuro to get 20% off. Cure HydrationGet 20% off your first order at https://curehydration.com/neuro with code NEURO. *** I'm Louisa Nicola — clinical neurophysiologist — Alzheimer's prevention specialist — founder of Neuro Athletics. My mission is to translate cutting-edge neuroscience into actionable strategies for cognitive longevity, peak performance, and brain disease prevention. If you're committed to optimizing your brain — reducing Alzheimer's risk — and staying mentally sharp for life, you're in the right place. Stay sharp. Stay informed. Join thousands who subscribe to the Neuro Athletics Newsletter → https://bit.ly/3ewI5P0 Instagram: https://www.instagram.com/louisanicola_/ Twitter : https://twitter.com/louisanicola_ Topics discussed:00:00:00 Introduction: The Exercise Intensity Revolution 00:01:02 The Study That Changes Everything 00:04:50 The Flawed Foundation: Why Guidelines Were Wrong 00:06:50 The Real Numbers: 4 to 10 Times More Powerful 00:08:53 The Brain Connection No One Is Talking About 00:15:32 Mechanism 1: Shear Stress and Cerebral Blood Flow 00:17:38 Mechanism 2: Lactate and BDNF Production 00:19:25 Mechanism 3: Type 2 Muscle Fibers and Myokines 00:24:30 Mechanism 4: Glucose Regulation and Mitochondrial Health 00:28:18 VILPA: The 3-Minute Daily Game Changer 00:32:16 Women and Menopause: The Critical Window 00:35:19 Practical Protocols: What to Do Starting Today Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of IDEA Collider, hosts Mike and Rick revisit a pivotal project from over a decade ago, the Reblozyl project, undertaken in collaboration with Acceleron and Celgene. Rick, the head of Growth and Innovation at IDEA, reminisces about the early days leading to the successful positioning and market shaping of luspatercept across different hematological indications. The episode features insightful contributions from Robin, Jane, and Tracy, key players from Acceleron and Celgene, who share their experiences and the collaborative efforts that enabled them to redefine the market. The discussion covers the strategic approach to overcoming competitive benchmarking, the importance of a unified messaging strategy, and the critical role of internal and external collaboration. They also reflect on the impact of their efforts on the lives of many patients and offer advice for future teams working on complex drug development projects. The episode concludes with a recognition of the rare and valuable collaborative human elements that drove the success of the Reblozyl project.Episode Timestamps;00:00 Introduction and Welcome00:27 Rick's Background and Project Overview02:31 Client Team Introductions05:32 Collaboration and Challenges13:29 Defining the Mechanism and Market Positioning23:52 Communication and Alignment27:48 Navigating Internal and External Communication33:15 Launch, Reflections, and Lessons Learned41:14 Final Thoughts and Acknowledgements Keep up with the guests;Robyn Blackburn  - Director Global Commercial Strategy CAR-T at Kite Pharmahttps://www.linkedin.com/in/robyn-blackburn-805b8b13/Jayne Butler - Director of Strategic Initiatives at Fingerpaint Brandinghttps://www.linkedin.com/in/jaynebutler/Tracey Sacco - Former SVP Global Strategic Marketing at Acceleronhttps://www.linkedin.com/in/tracey-sacco-53 2a034/Rick Ritacco - Head of Growth and Innovationhttps://www.linkedin.com/in/rritacco/ Follow Mike Rea On;Website: https://ideacollider.simplecast.com/X: https://x.com/ideapharmaLinkedIn: https://www.linkedin.com/in/bigidea/ Listen to more fantastic podcast episodes: https://ideacollider.simplecast.com/

Breuer, J. & Freud, S. (1893) On the Psychical Mechanism of Hysterical Phenomena: Preliminary Communication from Studies on Hysteria. I do not own the rights to this article. This is from the Standard Edition of the Complete Psychological Works of Sigmund Freud. This podcast is for educational purposes only.

Recent FDA actions are reshaping key aspects of drug and biologic development, including the Commissioner's National Priority Voucher program, the "plausible mechanism" pathway for personalized therapies, and new draft guidance aimed at streamlining biosimilars and interchangeables. Join Washington, D.C. partner Nathan Beaton and counsel Monica Groat and Chad Jennings as they discuss how these moves differ from traditional policy-making, as well as the practical implications for pricing, manufacturing, M&A, and litigation risk in the healthcare and life sciences industry.   This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York's Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York's Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200

Two questions I get a lot from people who are new to Biohacking and cognitive enhancers are...❓ Which Smart Drugs actually work and have science behind them?❔ Which Nootropic should I get started with?⚡ My answer to both questions is the same: PiracetamIt has a significant body of scientific evidence behind it; over 750 human studies and academic papers have been published about Piracetam on PubMed, with over ten meta-analysis papers in just the past decade.9:51 Scientific Research11:52 Memory Enhancement17:50 Mitochondrial Nootropic19:47 Stroke Recovery20:12 Cognitive Enhancer20:50 Verbal Fluency22:45 Cognitive Decline24:26 Vs Alzheimer's24:53 Mechanism of Action26:42 History27:13 Vs Depression29:50 Sources35:43 Piracetam Non-Responders?37:10 Tolerance37:28 Post-Piracetam Intelligence Deficit43:09 Addiction or Dependence?43:50 Experiential46:47 Featured in Fiction47:21 Dosage & Cofactors49:22 Side Effects & Risks56:23 ConclusionRead Meta-Analysis

https://www.otplinks.com 0:00 Welcome & today's focus: Retatrutide and “chasing the biggest number” 1:11 On The Pen intro, live schedule (Mon/Wed/Fri) & housekeeping 2:10 How Dave first heard about retatrutide (work trip, early phase 1 data) 3:35 Flashback clip: early excitement about retatrutide phase 3 trials 4:40 Why this new retatrutide data feels different for obesity medicine 5:32 TRIUMPH-4 trial overview: obesity + knee osteoarthritis population 7:00 Headline results: 28.7% average weight loss, surgery-level efficacy 8:47 Breaking down weight loss by dose (9 mg vs 12 mg; 25–35% loss rates) 11:05 What “efficacy estimate” really means (race-track analogy) 13:28 Real-world view: treatment-regimen estimate (20–23.7%) vs trial ideal 15:40 Mechanism refresher: GIP, GLP-1, glucagon and why RETA differs from TIRZ 18:05 Side effects, dysesthesia/allodynia & who stopped treatment (BMI differences) 21:02 Why the lower doses matter & who actually needs 30% weight loss 24:15 From “just make the scale go down” to quality of weight loss & body composition 28:05 Future focus: health, longevity, and peptides beyond hitting goal weight 30:40 Viewer Q&A: combining RETA + TIRZ, amylin (eloralintide) combos & “talk to your doctor” 34:38 How retatrutide changes the next decade of obesity treatment conversations 37:22 News update: high-dose Wegovy 7.2 mg approval in the EU & US outlook 40:55 Orforglipron oral GLP-1: liver-signal concerns & fast-track FDA review 45:20 Why small-molecule oral GLP-1s aren't the same as injectable peptides 48:40 New topic: Indiana “Safe Drug Act of 2025” and why Dave is concerned 51:02 Production caps, “essentially a copy” language & shifting power from prescribers to FDA 54:28 How the bill undermines personalization while ignoring real safety tools 57:05 Safety theater vs real safeguards: API sourcing, sterility & adverse-event reporting 59:45 Who actually gets hit: compliant 503A/503B compounders vs existing bad actors 1:02:05 Call to action: petition at otplinks.com & why patient voices matter 1:05:10 Change.org impact, media attention & centering the patient perspective 1:07:30 Final Q&A, subscribe, obesity.news email list & closing thanks Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

PREVIEW — Chris Riegel — "The Great Heist": China's Intellectual Property Theft Strategy. Riegel argues that Chinahas systematically employed intellectual property theft as a strategic mechanism to advance from technological desperation toward status as a near-peer American rival, systematically acquiring technologies while circumventing legitimate licensing and development pathways. Riegel documents that American corporations frequently ignored or tolerated Chinese IP theft in exchange for access to the lucrative Chinese domestic market, including the Cisco-Huaweicase illustrating corporate preference for market access over intellectual property protection. Riegel acknowledges that China now conducts original research and technological innovation, yet systematically rejects international intellectual property law regimes and refuses to recognize or enforce IP rights, maintaining institutional resistance to the legal frameworks protecting legitimate innovation and development within Western economies. 1922

Economist Paul Milgrom is celebrated for his Nobel Prize-winning work on auction theory and design. But he has published a wide range of other innovative, influential research throughout his career – including a book and articles emerging from his 1991-92 CASBS fellowship. Gani Aldashev (CASBS fellow, 2024-25) engages Milgrom on highlights of this often-collaborative or cross-disciplinary work on organizational behavior, the institutional roots of trust and cooperation, social choice for environmental policy, and more.PAUL MILGROM: Stanford faculty page | Personal website | Nobel Prize page | Nobel bio | Wikipedia page| CASBS page |Gani Aldashev: Georgetown faculty page | CASBS page | Google Scholar page |PAUL MILGROM WORKS REFERENCED IN THIS EPISODE:Economics, Organization, and Management (Prentice Hall, 1992), coauthored with John Roberts (CASBS fellow, 1991-92)"Multitask Principal-Agent Analyses: Incentive Contracts, Asset Ownership, and Job Design," The Journal of Law, Economics, and Organization (1991), coauthored with Bengt Holmstrom"Complementarities and Fit Strategy, Structure, and Organizational Change in Manufacturing," Journal of Accounting and Economics (1995), coauthored with John Roberts"Complementarities, Momentum, and the Evolution of Modern Manufacturing," The American Economic Review (1991), coauthored with Yingyi Qian, John Roberts"Complementarities and Systems: Understanding Japanese Economic Organization," Estudios Economicos (1994), coauthored with John Roberts"The Role of Institutions in the Revival of Trade: The Law Merchant, Private Judges, and the Champagne Fairs," Economics & Politics (1990), coauthored with Douglass North (CASBS fellow, 1987-88) and Barry Weingast (CASBS fellow, 1993-94)Learn about the Champagne Fairs on Wikipedia"Coordination, Commitment and Enforcement: The Case of the Merchant Guild," Journal of Political Economy (1994), coauthored with Avner Greif (CASBS fellow, 1993-94), Barry Weingast"Is Sympathy an Economic Value? Philosophy, Economics, and the Contingent Valuation Method," in Contingent Valuation: A Critical Assessment, J.A. Hausman, ed. (Elsevier, 1993)"Kenneth Arrow's Last Theorem," Journal of Mechanism and Institution Design (2024)Other works referenced in this episode:Oliver Williamson, The Economic Institutions of Capitalism: Firms, Markets, Relational Contracting (Mcmillan, 1985). Much of this book was written at CASBS during Williamson's 1977-78 CASBS fellowship.Works emerging from Milgrom's CASBS fellowshipsMilgrom's collaborations with, intellectual interactions with, or responses to other Nobel Prize winners in this episode:Oliver Williamson (CASBS fellow 1977-78, Nobel Prize 2009)Bengt Holmstrom (Nobel Prize 2016)Robert Wilson (CASBS fellow 1977-78, Nobel Prize 2020)Ronald Coase (CASBS fellow 1958-59, Nobel Prize 1991)Douglass North (CASBS fellow 1987-88, Nobel Prize 1993)Kenneth Arrow (CASBS fellow 1956-57, Nobel Prize 1972) Center for Advanced Study in the Behavioral Sciences (CASBS) at Stanford UniversityExplore CASBS: website|Bluesky|X|YouTube|LinkedIn|podcast|latest newsletter|signup|outreach​Human CenteredProducer: Mike Gaetani | Audio engineer & co-producer: Joe Monzel |

Livestream with Yuri Rashkin----------SILICON CURTAIN FILM FUNDRAISERA project to make a documentary film in Ukraine, to raise awareness of Ukraine's struggle and in supporting a team running aid convoys to Ukraine's front-line towns.https://buymeacoffee.com/siliconcurtain/extras----------https://car4ukraine.com/campaigns/autumn-harvest-silicon-curtainDonate and Receive - Collectable PatchAUTUMN HARVEST TRUCKS 2025. Part of our 2025 patch collection. Everyone who contributes €100 (~$115) or more will be able to receive it.For our Autumn patch, we present the Galician Lion. The rampant lion represents power and intelligence. It has represented Western Ukrainian people since the 1100s. The Ruthenian lion, also known as the Ukrainian lion or Galician lion, was featured on the historic coat of arms of: The Kingdom of Galicia-Volhynia (Ruthenia)1199-1349, The battle flag of the Lviv land in the Battle of Tannenberg, 1410 The Ruthenian Voivodeship (Administration) 1434-1772 and The Western Ukrainian People's Republic 1918-1919. The Ukrainian national liberation movement, 1948----------SILICON CURTAIN LIVE EVENTS - FUNDRAISER CAMPAIGN Events in 2025 - Advocacy for a Ukrainian victory with Silicon Curtainhttps://buymeacoffee.com/siliconcurtain/extrasOur events of the first half of the year in Lviv, Kyiv and Odesa were a huge success. Now we need to maintain this momentum, and change the tide towards a Ukrainian victory. The Silicon Curtain Roadshow is an ambitious campaign to run a minimum of 12 events in 2025, and potentially many more. Any support you can provide for the fundraising campaign would be gratefully appreciated. https://buymeacoffee.com/siliconcurtain/extrasWe need to scale up our support for Ukraine, and these events are designed to have a major impact. Your support in making it happen is greatly appreciated. All events will be recorded professionally and published for free on the Silicon Curtain channel. Where possible, we will also live-stream events.https://buymeacoffee.com/siliconcurtain/extras----------SUPPORT THE CHANNEL:https://www.buymeacoffee.com/siliconcurtainhttps://www.patreon.com/siliconcurtain----------TRUSTED CHARITIES ON THE GROUND:Save Ukrainehttps://www.saveukraineua.org/Superhumans - Hospital for war traumashttps://superhumans.com/en/UNBROKEN - Treatment. Prosthesis. Rehabilitation for Ukrainians in Ukrainehttps://unbroken.org.ua/Come Back Alivehttps://savelife.in.ua/en/Chefs For Ukraine - World Central Kitchenhttps://wck.org/relief/activation-chefs-for-ukraineUNITED24 - An initiative of President Zelenskyyhttps://u24.gov.ua/Serhiy Prytula Charity Foundationhttps://prytulafoundation.orgNGO “Herojam Slava”https://heroiamslava.org/kharpp - Reconstruction project supporting communities in Kharkiv and Przemyslhttps://kharpp.com/NOR DOG Animal Rescuehttps://www.nor-dog.org/home/-----------

From an interview discussing the negotiations-mechanism with Israel, conditions for economic recovery, Hezbollah's status today and what hope means in 2025 0:00 Mechanism for negotiations 1:53 Conditions for economic recovery 3:10 Hezbollah today 3:57 Meaning of hope

In this episode, we explore the science and clinical potential of molecular hydrogen — one of the smallest and most fascinating therapeutic molecules in medicine. Once dismissed as biologically inert, hydrogen gas is now recognized for its strong antioxidant, anti-inflammatory, and cell-signaling effects. We'll look at how integrative medicine practitioners are using hydrogen therapy to support mitochondrial health, reduce oxidative stress, and improve recovery across various conditions. Join us as we examine the research, mechanisms, and practical uses of molecular hydrogen in modern clinical care.   Key Takeaways To Tune In For: (01:57) – Greg Mann's Healing Journey (07:04) – The Origin of Hydrogen Research (11:56) – Molecular Hydrogen's Mechanism of Action (15:20) – Hydrogen's Clinical Applications (19:54) – Hydrogen for Strokes and Brain Health (39:15) – Ensuring Hydrogen Purity and Access   Resources talked about in this episode: YouTube

⭐ Guest Bio – Ola Wolny (Self Mastery Quest)Ola Wolny is the creator of Self Mastery Quest, a platform dedicated to decoding the deeper, hidden structure of the reality we inhabit. Her work focuses on how human consciousness interacts with the architecture of this realm, emphasizing that the zodiac is not merely symbolic—but a functional mechanism, a coded matrix system that predetermines energetic pathways, lessons, patterns, and incarnational contracts.Through her YouTube teachings, her private sessions, and her research, Ola guides people through identifying where they are trapped in the zodiac-based programming and how to reclaim autonomy, intuition, and soul sovereignty.Her work merges gnosis, esoteric cosmology, and practical self-mastery.Website: SelfMasteryQuest.comYouTube: https://www.youtube.com/@olawolnyselfmasteryquest

In this episode, Dr. Sharon Niv discusses her work at Joyus, a public benefit company focused on revolutionizing mental health care through personalized at-home microdose ketamine treatments.    Dr. Sharon explains the history of ketamine as a treatment for mental health, its mechanisms of action, and the importance of community support in the healing process.    Nick asks Dr. Sharon questions that address common concerns and stigma surrounding ketamine treatment, emphasizing its low risk and potential benefits.    Their conversation also explores the role of neuroplasticity in mental health recovery and the future of AI in therapy.    Dr. Sharon provides insights into personalized treatment protocols and encourages both patients and therapists to consider the benefits of ketamine therapy.   Key Takeaways:    Dr. Sharon Niv is a cognitive psychologist bridging neuroscience and therapy. Joyus offers personalized at-home microdose ketamine treatments. Ketamine was first synthesized in the 1950s and is used safely in medical settings. The drug has shown promise in treating severe depression and suicidality. Ketamine works primarily on the glutamate system, unlike traditional psychedelics. Lower doses of ketamine can provide therapeutic benefits without destabilizing experiences. Community support is crucial for individuals undergoing ketamine treatment. Neuroplasticity allows the brain to change and adapt, which is enhanced by ketamine. Personalized treatment protocols are essential for effective ketamine therapy. AI has potential in mental health, but should not replace human therapists.   Chapters   00:00 Introduction to Dr. Sharone Niv and Her Work 02:58 The Journey to Psychology and Entrepreneurship 05:47 The History and Safety of Ketamine 08:45 Ketamine as a Treatment for Mental Health 11:36 Understanding Ketamine's Mechanism and Effects 14:44 The Psycholytic State and Its Benefits 17:40 Addressing Stigma and Concerns Around Psychedelics 20:48 The Joyus Approach to Microdosing Ketamine 23:24 Personal Experiences and Emotional Release 26:45 The Importance of Connection and Exploration 27:14 Exploring Psychoactive Substances and Their Impact 28:14 The Tragic Story of Matthew Perry 32:56 Neuroscience and Mental Health: The Role of Neuroplasticity 39:45 Personalized Treatment Protocols for Mental Health 45:22 Community Support in Mental Health Treatment 47:48 The Future of AI in Therapy 53:07 The Dark Side of AI in Mental Health 54:37 Innovative Uses of AI in Therapy 56:09 Training Therapists for New Technologies 59:43 The Journey of Integrating Ketamine Treatment 01:02:09 Encouragement for Patients and Therapists 01:04:22 Understanding the Risks and Benefits of Ketamine 01:09:52 Navigating the Decision to Try Ketamine 01:12:08 Practical Considerations for Microdosing Ketamine Find Dr. Sharon Niv here: Instagram: https://www.instagram.com/joyous.team/  Facebook: https://www.facebook.com/joyous.friends   Website: https://www.joyous.team/  LinkedIn: https://www.linkedin.com/in/sharon-niv/ | https://www.linkedin.com/company/joyousteam/ Find Nick Thompson here: Instagram: https://www.instagram.com/nthompson513/  |  https://www.instagram.com/the_ucan_foundation/  YouTube: https://www.youtube.com/@EyesWideOpenContent   LinkedIn: https://www.linkedin.com/in/nickthompson13/     UCAN Foundation: https://theucanfoundation.org/  Website: https://www.engagewithnick.com/     

2/8. Pigeons: The Great Communicators and Wartime Heroes — Steven Moss — Moss discusses the humble pigeon as a paradoxical feral bird species possessing extraordinary homing capabilities that made it invaluable as a communications mechanism. Although the famous narrative of Nathan Rothschild using pigeons following the Battle of Waterloo is apocryphal, pigeons were genuinely crucial wartime messengers. Moss emphasizes that pigeons were essential during the D-Day invasion due to radio silence protocols, and the celebrated pigeon Cher Ami saved imperiled soldiers during World War I. Moss notes that British forces even systematically killed Peregrine Falcons to protect pigeon communications, inadvertently contributing to the species' subsequent endangerment and near-extinction. 1869

Cristina Gomez discusses the latest findings on interstellar object 3I/ATLAS, including Dr. Avi Loeb's new theory that its jets are pulsating like a heartbeat every 16 hours, the mysterious data changes on NASA's JPL website after the Hill radius coincidence was discovered, and why hundreds of telescopes worldwide are now tracking this object as it heads toward Jupiter.To see the VIDEO of this episode, click or copy link - https://youtu.be/bCPe6UTMMwIVisit my website with International UFO News, Articles, Videos, and Podcast direct links -www.ufonews.co00:00 - 3I/ATLAS Pulsating Like A Heartbeat00:45 - The Jupiter 3I/ATLAS Trajectory01:55 - JPL Changed The 3I/ATLAS Data03:28 - The Perpendicular Object04:19 - 3I/ATLAS Pulsating Jets05:31 - 3I/ATLAS Natural Or Technological?07:00 - What The Data Could RevealBecome a supporter of this podcast: https://www.spreaker.com/podcast/strange-and-unexplained--5235662/support.

Dr. Suresh Durgam (Intra-Cellular Therapies, a Johnson & Johnson Company, Bedminster, NJ) joins AJP Audio to discuss a phase 3 randomized controlled trial looking at the use of the antipsychotic medication lumateperone as adjunctive to antidepressant therapy in the treatment of patients with major depressive disorder. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin discusses the rest of the December issue of the Journal. 00:48   Durgam interview 03:09   Mechanism of action 04:44   Patient-reported outcomes 06:31   Immediate clinical implications 07:32   Limitations 08:08   Further research 09:25   Kalin interview 09:38   Durgam et al. 13:09   Lin et al. 17:22   Brodsky et al. Transcript Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it. Subscribe to the podcast here. Listen to other podcasts produced by the American Psychiatric Association. Browse articles online. How authors may submit their work. Follow the journals of APA Publishing on Twitter. E-mail us at ajp@psych.org

After graduating from Caltech with a degree in physics, Scott Sperling pursued computer science and ended up working in rocket science. He’s also been a Christian for decades and has applied his analytical mind to Bible study, especially on his website ScriptureStudies.com. In this interview I ask him about his paper, “A Hypothesis for the Mechanism of Bodily Resurrection” in which he explains how God can raise the dead on the basis of DNA and the neural connectome. He does not see any need for the existence of an immaterial soul or dualism to account for biblical resurrection.   Listen on Spotify   Listen on Apple Podcasts —— Links —— See Scott Sperling’s studies at his website where you can also download his paper. Support Restitutio by donating here Join our Facebook group, follow on X @RestitutioSF or Instagram @Sean.P.Finnegan Leave a 90 second voice message via SpeakPipe with questions or comments and we may play it out on the air Who is Sean Finnegan?  Read his bio here Get Finnegan’s book, Kingdom Journey to learn about God’s kingdom coming on earth as well as the story of how Christianity lost this pearl of great price. Get the transcript of this episode Intro music: Good Vibes by MBB Attribution-ShareAlike 3.0 Unported (CC BY-SA 3.0) Free Download / Stream: Music promoted by Audio Library.

Dietitians Aidan Muir and Torwen Eerkens unpack the role of bicarbonate soda as a supplement for athletic performance. They explore the mechanism, types of exercise which see a benefit, percentage improvement, risks and practical recommendations for incorporating bicarb your regime.     Time stamps (00:53) - Mechanism for Athletes (1:50) - Types of Exercise  (2:52) - Dosage & How to Take (3:53) - What Are the Risks?  (5:25) - Practical Recommendations for Navigating Risks (6:21) - Research on Running and Endurance Events  (8:18) - Research on Strength Performance (8:56) - Bicarb vs Beta Alanine (10:07) - When Do We Recommend This in Practice? WEBSITE:  https://www.idealnutrition.com.au/ PODCAST:  https://www.idealnutrition.com.au/podcast/ INSTAGRAM:  https://www.instagram.com/idealnutrition__/?hl=en Our dietitians

When 18-year-old Anna Kepner was found hidden under a bed inside a cruise ship cabin, the story immediately drew national attention — not because of what investigators discovered, but because of all the things they didn't. No intruder. No external threat. No clear cause of death. Just a 16-year-old stepsibling who now sits at the center of a legal and emotional storm. Tonight on Hidden Killers, we dig into the legal tensions surrounding this case — the gaps, the unknowns, the strict limitations of the juvenile system, and the uncomfortable reality that many of these answers may never become public. With attorney and former prosecutor Bob Motta, we explore every realistic scenario investigators must consider: accident, panic, trauma, a moment of fear that spiraled, an altercation without intent, a medical event mishandled, or an intentional act. The law doesn't get to pick the neat version — it has to test all of them. We also break down the implications of the stepson's claim that he “doesn't remember what happened.” Legally, that can indicate trauma, shock, dissociation, or a panic-response blackout — all of which dramatically complicate the question of charges. Because intent matters. Mechanism matters. And mental state matters. We look at why certain charges are possible, why some are unlikely, and why others — like premeditated murder — simply don't fit the known facts. And we explain the Fifth Amendment move by the stepmother: a headline-grabbing moment that creates more confusion than clarity. Most importantly, we dive into the biggest question: how does a case like this realistically end? A juvenile plea? Treatment? No charges? Or a sealed resolution the public will never see? This case is heartbreaking, confusing, and bound by legal blinders that make it even harder to understand. But tonight, we break down what the law actually says — not what the internet assumes. #AnnaKepner #CruiseCase #HiddenKillers #TrueCrimeToday #LegalBreakdown #JuvenileCase #BobMotta #CrimeAnalysis #JusticeSystem #InvestigationUpdate Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/@hiddenkillerspod Instagram https://www.instagram.com/hiddenkillerspod/ Facebook https://www.facebook.com/hiddenkillerspod/ Tik-Tok https://www.tiktok.com/@hiddenkillerspod X Twitter https://x.com/tonybpod Listen Ad-Free On Apple Podcasts Here: https://podcasts.apple.com/us/podcast/true-crime-today-premium-plus-ad-free-advance-episode/id1705422872

When 18-year-old Anna Kepner was found hidden under a bed inside a cruise ship cabin, the story immediately drew national attention — not because of what investigators discovered, but because of all the things they didn't. No intruder. No external threat. No clear cause of death. Just a 16-year-old stepsibling who now sits at the center of a legal and emotional storm. Tonight on Hidden Killers, we dig into the legal tensions surrounding this case — the gaps, the unknowns, the strict limitations of the juvenile system, and the uncomfortable reality that many of these answers may never become public. With attorney and former prosecutor Bob Motta, we explore every realistic scenario investigators must consider: accident, panic, trauma, a moment of fear that spiraled, an altercation without intent, a medical event mishandled, or an intentional act. The law doesn't get to pick the neat version — it has to test all of them. We also break down the implications of the stepson's claim that he “doesn't remember what happened.” Legally, that can indicate trauma, shock, dissociation, or a panic-response blackout — all of which dramatically complicate the question of charges. Because intent matters. Mechanism matters. And mental state matters. We look at why certain charges are possible, why some are unlikely, and why others — like premeditated murder — simply don't fit the known facts. And we explain the Fifth Amendment move by the stepmother: a headline-grabbing moment that creates more confusion than clarity. Most importantly, we dive into the biggest question: how does a case like this realistically end? A juvenile plea? Treatment? No charges? Or a sealed resolution the public will never see? This case is heartbreaking, confusing, and bound by legal blinders that make it even harder to understand. But tonight, we break down what the law actually says — not what the internet assumes. #AnnaKepner #CruiseCase #HiddenKillers #TrueCrimeToday #LegalBreakdown #JuvenileCase #BobMotta #CrimeAnalysis #JusticeSystem #InvestigationUpdate Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/@hiddenkillerspod Instagram https://www.instagram.com/hiddenkillerspod/ Facebook https://www.facebook.com/hiddenkillerspod/ Tik-Tok https://www.tiktok.com/@hiddenkillerspod X Twitter https://x.com/tonybpod Listen Ad-Free On Apple Podcasts Here: https://podcasts.apple.com/us/podcast/true-crime-today-premium-plus-ad-free-advance-episode/id1705422872

When 18-year-old Anna Kepner was found hidden under a bed inside a cruise ship cabin, the story immediately drew national attention — not because of what investigators discovered, but because of all the things they didn't. No intruder. No external threat. No clear cause of death. Just a 16-year-old stepsibling who now sits at the center of a legal and emotional storm. Tonight on Hidden Killers, we dig into the legal tensions surrounding this case — the gaps, the unknowns, the strict limitations of the juvenile system, and the uncomfortable reality that many of these answers may never become public. With attorney and former prosecutor Bob Motta, we explore every realistic scenario investigators must consider: accident, panic, trauma, a moment of fear that spiraled, an altercation without intent, a medical event mishandled, or an intentional act. The law doesn't get to pick the neat version — it has to test all of them. We also break down the implications of the stepson's claim that he “doesn't remember what happened.” Legally, that can indicate trauma, shock, dissociation, or a panic-response blackout — all of which dramatically complicate the question of charges. Because intent matters. Mechanism matters. And mental state matters. We look at why certain charges are possible, why some are unlikely, and why others — like premeditated murder — simply don't fit the known facts. And we explain the Fifth Amendment move by the stepmother: a headline-grabbing moment that creates more confusion than clarity. Most importantly, we dive into the biggest question: how does a case like this realistically end? A juvenile plea? Treatment? No charges? Or a sealed resolution the public will never see? This case is heartbreaking, confusing, and bound by legal blinders that make it even harder to understand. But tonight, we break down what the law actually says — not what the internet assumes. #AnnaKepner #CruiseCase #HiddenKillers #TrueCrimeToday #LegalBreakdown #JuvenileCase #BobMotta #CrimeAnalysis #JusticeSystem #InvestigationUpdate Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/@hiddenkillerspod Instagram https://www.instagram.com/hiddenkillerspod/ Facebook https://www.facebook.com/hiddenkillerspod/ Tik-Tok https://www.tiktok.com/@hiddenkillerspod X Twitter https://x.com/tonybpod Listen Ad-Free On Apple Podcasts Here: https://podcasts.apple.com/us/podcast/true-crime-today-premium-plus-ad-free-advance-episode/id1705422872

How we can use an output-based system to judge whether or not different kinds of technology achieve understanding or intelligence. Become a Member: https://danielmiessler.com/upgradeSee omnystudio.com/listener for privacy information.

A brutal incident where a woman gets hit by a truck leaves her with a multitude of injuries, most notably both of her legs bent into a position best described as "frog legs." She's in good spirits and her vitals are good, but her legs bent at that angle means that she cannot fit into our team's helicopter. How does our team get her legs back into place without causing further trauma or risking her stable vitals? Complicating factors is the extremely uneven ground because they're in a cow pasture and the risk of infection is extremely high because the team and the patient are surrounded by cow patties. There is no training for this exact scenario, so how does our team adapt and apply the training they have to this unique situation? This episode of AMPED digs in.   Interested in obtaining CE credit for this episode? Visit OnlineAscend.com to learn more. Listeners can purchase individual episode credits or subscribe to the Critical Care Review Bundle and gain access to all episode CE Credits.    We are joined by:   Aaron Botzow, NRP, FP-C     Drew Gill, BSN, RN, CEN     Michael Eastman DO   Click here to download this episode today! As always thanks for listening and fly safe! Hawnwan Moy MD FACEP FAEMS John Wilmas MD FACEP FAEMS Nyssa Hattaway, BA, BSN, RN, CEN, CPEN, CFRN

Bisacodyl, commonly known by the brand name Dulcolax, is a stimulant laxative widely used for short-term relief of constipation and bowel preparation before procedures. It works by directly stimulating the enteric nerves in the colon, increasing peristalsis, and promoting bowel evacuation. Mechanism of Action:Bisacodyl acts primarily on the large intestine. It stimulates intestinal smooth muscle and alters water and electrolyte transport, increasing fluid accumulation in the bowel and triggering defecation. The result is a bowel movement typically within 6–12 hours orally or within 15–60 minutes when given rectally. Dosage Forms and Dosing:Bisacodyl is available as oral tablets (5 mg) and rectal suppositories (10 mg). Typical adult dosing is 5–15 mg by mouth once daily or 10 mg rectally as needed. It's often used for acute constipation, bowel prep, or to prevent straining in specific medical situations. Adverse Effects:Common side effects include abdominal cramping, diarrhea, and nausea. Chronic or excessive use may lead to electrolyte imbalances, dehydration, and laxative dependence. Drug Interactions and Monitoring:Concurrent use with antacids, proton pump inhibitors, or milk may cause premature dissolution of enteric-coated tablets, leading to gastric irritation. Monitoring for bowel regularity, hydration status, and signs of electrolyte imbalance is important—especially in elderly or debilitated patients.

Pre-Order The Forever Strong PLAYBOOK and receive exclusive bonuses: https://drgabriellelyon.com/playbook/Want ad-free episodes, exclusives and access to community Q&As? Subscribe to Forever Strong Insider: https://foreverstrong.supercast.comIn this fascinating episode, Dr. Gabrielle Lyon talks with neuroscientist Dr. Ben Rein, PhD (author of Why Brains Need Friends), about the science of social connection, emotion, and cognitive health. Dr. Rein, an expert in neurobiology and psychedelic research, reveals the cutting-edge studies that explain why loneliness is as damaging as smoking and how our digital world is affecting our brain's ability to connect.They discuss the neurochemistry of love, the controversial use of MDMA in therapy, and whether AI can ever truly replace human intimacy. This conversation provides an essential look at the biological drivers of happiness, performance, and long-term brain health.Chapter Markers:0:00 - MDMA (Molly): The History & Therapeutic Benefits 5:59 - The Legal Status of MDMA for PTSD 6:44 - The Safety and Effectiveness of MDMA in Clinical Trials 8:29 - PTSD (The Amygdala Alarm) 9:41 - How MDMA Soothes the Amygdala to Access Memory 11:42 - Is There an Alternative to MDMA? (Ketamine's Mechanism) 13:16 - Ketamine and Neuroplasticity for Depression 15:48 - Botox and Empathy: 18:12 - The Problem of Volume: How Screens Depersonalize Interaction 19:48 - The Virtual Disengagement Hypothesis Explained 25:00 - Defining Cognitive and Emotional Empathy 29:43 - MDMA's Link to Serotonin & Social Reward 31:04 - Do SSRIs Have Pro-Social Effects? 36:10 - The Science of Likability and "Easy to Read" Faces 40:10 - Top 3 Ways to Be More Likable49:49 - The Likability Gap: Why You Underestimate How Well-Liked You Are 56:59 - The Neurobiology of Oxytocin, Dopamine, and Serotonin1:09:23 - The Goldilocks Zone of Empathy 1:15:58 - Narcolepsy 1:18:16 - Alcohol: Why the Neurotoxin is Bad for Brain Health 1:21:47 - Exercise and Neurogenesis1:22:27 - Sex, Orgasm, and Oxytocin Release 1:25:06 - Oxytocin During Childbirth Who is Ben Rein:Dr. Ben Rein is an award-winning neuroscientist and Chief Science Officer of the Mind Science Foundation, where he supports early-career researchers in neuroscience. He earned his PhD from SUNY Buffalo and completed postdoctoral training at Stanford University, publishing over 20 peer-reviewed papers on autism, empathy, MDMA, and digital behavior. Recognized by the NIH, the Society for Neuroscience, and Sigma Xi, he also serves as a scientific advisor to more than 20 organizations. With over one million followers and 75 million video views, Dr. Rein is celebrated for making neuroscience accessible to the public and has been featured by outlets such as Good Morning America, ABC News, and PopularMechanics.Thank you to our sponsors:BodyHealth: Use code LYON20 to get 20% off your first order https://www.bodyhealthaffiliates.com/73L4QL3/7XDN2/BON CHARGE Holiday Sale https://boncharge.com for 25% off Pique 20% off for life: https://Piquelife.com/DRLYONFind Ben Rein at: Website: https://www.benrein.com/Instagram: https://www.instagram.com/dr.benrein/#TikTok: https://www.tiktok.com/@dr.benrein?lang=enFacebook:

Unpacking market volatility, stablecoins, and Kraken's strategy with Co-CEO David Ripley. Kraken Co-CEO David Ripley joins CoinDesk's Jennifer Sanasie and Andy Baehr to discuss the firm's record-breaking Q3 growth and its strategy to merge traditional finance with crypto by moving into futures and equities trading. Ripley highlights the "network effect" that has made stablecoins the default settlement currency for exchanges and integrated crypto businesses. He also addresses the compression of Bitcoin volatility and how Kraken is catering to both seasoned individual pro traders and the broader, derivatives-shy retail consumer base. - Break the cycle of exploitation. Break down the barriers to truth. Break into the next generation of privacy. Break Free. Free to scroll without being monetized. Free from censorship. Freedom without fear. We deserve more when it comes to privacy. Experience the next generation of blockchain that is private and inclusive by design. Break free with Midnight, visit ⁠⁠⁠⁠⁠⁠midnight.network/break-free⁠⁠⁠⁠⁠⁠ - OwlTing (Nasdaq: OWLS) is building invisible rails for global payments. With OwlPay, businesses and users can bridge fiat and stablecoins, send money instantly across borders, and access stablecoin checkout at lower costs. Licensed worldwide, OwlTing delivers secure, compliant, and regulated infrastructure for the digital economy. Learn more at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠owlting.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. - Genius Group has partnered with CoinDesk for Bitcoin Treasury Month, launching the Genius x CoinDesk Quest. Participants can join the Bitcoin Academy, complete free microcourses from experts like Natalie Brunell and Saifedean Ammous, and enter to win 1,000,000 GEMs (worth 1 BTC) promoting bitcoin education and adoption. Learn more at: ⁠https://www.geniusgroup.ai/coindesk-bitcoin-treasury-month/⁠ - This episode was hosted by Jennifer Sanasie and Andy Baehr.

Unpacking market volatility, stablecoins, and Kraken's strategy with Co-CEO David Ripley. Kraken Co-CEO David Ripley joins CoinDesk's Jennifer Sanasie and Andy Baehr to discuss the firm's record-breaking Q3 growth and its strategy to merge traditional finance with crypto by moving into futures and equities trading. Ripley highlights the "network effect" that has made stablecoins the default settlement currency for exchanges and integrated crypto businesses. He also addresses the compression of Bitcoin volatility and how Kraken is catering to both seasoned individual pro traders and the broader, derivatives-shy retail consumer base. - Break the cycle of exploitation. Break down the barriers to truth. Break into the next generation of privacy. Break Free. Free to scroll without being monetized. Free from censorship. Freedom without fear. We deserve more when it comes to privacy. Experience the next generation of blockchain that is private and inclusive by design. Break free with Midnight, visit ⁠⁠⁠⁠⁠⁠midnight.network/break-free⁠⁠⁠⁠⁠⁠ - OwlTing (Nasdaq: OWLS) is building invisible rails for global payments. With OwlPay, businesses and users can bridge fiat and stablecoins, send money instantly across borders, and access stablecoin checkout at lower costs. Licensed worldwide, OwlTing delivers secure, compliant, and regulated infrastructure for the digital economy. Learn more at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠owlting.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. - Genius Group has partnered with CoinDesk for Bitcoin Treasury Month, launching the Genius x CoinDesk Quest. Participants can join the Bitcoin Academy, complete free microcourses from experts like Natalie Brunell and Saifedean Ammous, and enter to win 1,000,000 GEMs (worth 1 BTC) promoting bitcoin education and adoption. Learn more at: ⁠https://www.geniusgroup.ai/coindesk-bitcoin-treasury-month/⁠ - This episode was hosted by Jennifer Sanasie and Andy Baehr.

Are supplements helping you — or wasting your money? In this episode of The Exam Room Podcast, Dr. Gemma Newman joins Chuck Carroll to break down the science, myths, and marketing behind the multibillion-dollar supplement industry. Discover which supplements are truly worth taking, which can be harmful in excess, and how to build better health through a whole-food, plant-based diet. Whether you're taking vitamin B12, vitamin D, omega-3, or a daily multivitamin, Dr. Newman explains how to personalize your nutrition safely and effectively. In This Episode: - The truth about supplements and what's actually backed by science - Why multivitamins don't extend lifespan — and can sometimes harm your health - How to get vitamin B12 safely - The risks of "natural" supplements - The difference between fish oil vs. algae-based omega-3s - Dr. Newman's SMART method: Science, Mechanism, Aim, Risk vs. Benefit, Tracking - How to spot fake supplement ads and AI deepfakes online Known as The Plant Power Doctor, Dr. Newman is a respected physician and lifestyle medicine expert helping patients reverse chronic disease through evidence-based nutrition and lifestyle change.